Articles by : Sponsored Content,

SPONSORED CONTENT

If you are reading this article, then you’re likely aware of the 340B drug discount program, the U.S. federal government program that requires drug manufacturers to provide outpatient drugs to covered entities at significantly reduced prices.

Covered entities may effectively navigate this incredibly complex program, maximize their benefits,

SPONSORED CONTENT

At AllianceRx Walgreens Pharmacy, each covered entity we meet with describes circumstances unique to its hospital, patients, and pharmacy arrangements. The common element for all is the increasing complexity of 340B programming – often changing by the day. Other

SPONSORED CONTENT

In the dynamic world of 340B, identifying and resolving noncompliance issues can be a time-consuming task. Stakeholders can streamline, simplify, and strengthen their 340B operations with solutions from Apexus, which brings together a wealth of knowledge, from credentialing to noncompliance resolution, to help manage a smooth and successful 340B program. Since

SPONSORED CONTENT

Maximizing savings and validating compliance is a necessary process of any 340B entity and not all reporting is the same. Regardless of automatic reporting features, there are many practical reports that use Data Analytics to verify accuracy of data and most importantly, compliance.

SPONSORED CONTENT

For decades, the 340B drug pricing program has served an important purpose by helping hospitals and other covered entities receive discounted prices on drugs to offset care provided to vulnerable, underserved populations.

But over the past several years, drug companies have started pushing back on the 340B

SPONSORED CONTENT

In Democracy in America, French sociologist and political theorist Alexis de Tocqueville spoke of the importance of advocacy to American civil society: “In the United States, as soon as several inhabitants have taken an opinion or an idea they wish to promote in society, they seek

SPONSORED CONTENT

As the dispute with drug manufacturers over 340B contract pharmacies drags on, Sentry Data Systems has unveiled a suite of resources and capabilities to help covered entities decide on their next steps. It’s no coincidence that this has happened as Sentry integrates more closely as part of The

SPONSORED CONTENT

Hospitals, community health centers and other covered entities participating in the 340B program are not-for-profit and the purpose of 340B is to help them stretch their scarce federal resource dollars to enhance patient care. The mission of covered entities